AI-assisted, human-published

03/14/2025 /Funding Events

Nimblemind.ai Secures $2.5 Million Funding to Accelerate AI-Driven Healthcare Data Infrastructure Mission

treatment  hospital  clinic  medicine  laboratory  diagnosis  patient  healthcare  hospital  hospital  hospital  hospital  hospital  patient  patient  patient  healthcare  healthcare  healthcare
AI-assisted, human-published

Nimblemind.ai, a platform aiming to help healthcare providers structure and leverage their clinical data through AI, has successfully raised $2.5 million in funding. The investment round was led by Bread & Butter Ventures and saw contributions from Great Oaks Venture Capital, SpringTime Ventures, Stone Mountain Ventures, Victorum Capital, Techstars, and strategic HC angel investors.

 

This funding is intended to expedite Nimblemind.ai's goal of preparing unstructured healthcare data for AI applications. By organizing and labeling clinical datasets, the company addresses a major obstacle in healthcare AI by ensuring access to high-quality, structured multi-modal datasets. Pi Zonooz, CEO & Co-Founder of Nimblemind.ai, emphasized the pivotal role of well-structured data in realizing the full potential of AI in healthcare, while maintaining data sovereignty and compliance.

 

Nimblemind.ai has established partnerships with various healthcare organizations in the US and Asia, enabling clinicians to convert raw patient data into structured, AI-ready formats for improved decision-making, predictive analytics, and non-clinical revenue opportunities. The company's efforts have garnered praise from healthcare leaders, such as Lynn M Madden, PhD, CEO of APT Foundation, and Mary Grove, Managing Director of Bread & Butter Ventures, who lauded the platform's impact on personalized, proactive care and its potential to revolutionize healthcare through AI.

 

With this funding, Nimblemind.ai plans to expand its specialty-specific AI models, enhance its platform's capabilities, and onboard more healthcare providers seeking to leverage AI for better patient outcomes.

 

Source: PR NewsWire

Featured










Latest headlines







join us

Join us for funding and investment opportunities.

Stay connected!

If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here

©2023 VentureCapital.com